* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Biochemistry - u.arizona.edu
Survey
Document related concepts
Brucellosis wikipedia , lookup
Hospital-acquired infection wikipedia , lookup
Middle East respiratory syndrome wikipedia , lookup
Meningococcal disease wikipedia , lookup
Onchocerciasis wikipedia , lookup
Sexually transmitted infection wikipedia , lookup
Marburg virus disease wikipedia , lookup
Eradication of infectious diseases wikipedia , lookup
Leishmaniasis wikipedia , lookup
Coccidioidomycosis wikipedia , lookup
Leptospirosis wikipedia , lookup
Visceral leishmaniasis wikipedia , lookup
Schistosomiasis wikipedia , lookup
Chagas disease wikipedia , lookup
Fasciolosis wikipedia , lookup
African trypanosomiasis wikipedia , lookup
Transcript
Pathology Lecture 48 Infectious Hepatitis 1) Understand the primary nature of hepatotrophic viral hepatitis. Varying degrees of parenchymal necrosis with no cellular reaction or minimal lymphocytic response. Hepatocellular necrosis occurs through ballooning degeneration, but may occur through apoptosis (shrunken eosinophilic hepatocytes called Councilman or Acidophilic bodies). Viral infection may result in: 1) extensive necrosis leading to death, 2) symptomatic disease with rapid recovery, 3) symptomatic disease with delayed recovery, 4) symptomatic disease with chronic damage and cirrhosis, or 5) persistence of disease with minimal effect (carriers). 2) Know the heptotrophic viruses. Review virology notes. HAV, HBV, HCV, HDV, and HEV. 3) Recognize the short-term acute complications and long-term sequela of hepatotrophic viruses. HAV: 0.1% fatality, usually resolves, not chronic, no carrier state. HBV: 2% acute necrosis and death, 10-33% chronic disease, 5-10% healthy carriers. HCV: >50% chronic disease. HDV: simultaneous infection with HBV 3-4% fulminant disease, superimposed on chronic HBV = acute, fulminant, or chronic disease (80% of patients) with cirrhosis. HEV: not associated with chronic liver disease or persistent viremia. 4) Know Hepatitis B viral disease well because of its global significance. <1% die of acute disease, 5-10% healthy carriers, 4% with chronic disease (Chronic Persistent Hepatitis) will eventually recover Cirrhosis is late to come, 60-65% sub-clinical disease, 10-15% with chronic disease will end up with Hepatocellular Carcinoma 5) Hepatitis C is relatively new but is a very important common disease with better understanding of the virus now. 150,000-170,000 cases annually in the U.S. Small single stranded RNA virus, Blood borne disease 1% of population are seropositive, 50-85% hemophiliacs and 8% people with hemodialyis are seropositive 50% progress to chronic disease, Incubation period is 2-26 weeks Clinical course in milder, Anti-HCV IgG does not provide immunity 6) Bacterial infections of the liver are usually secondary to systemic or GI infection. In developing countries parasitic liver disease and abscesses are common (e.g. amoebic liver abscess, ecchinococcal cysts, liver flukes, etc.), but is rarely seen in the West (mostly immigrants). US incidence of liver abscess is from bacterial organisms, which reach the liver through the portal vein, hepatic artery, or bile duct (ascending cholangitis). A number of bacteria can infect the liver directly, including Staphylococcus aureus in the setting of toxic shock syndrome, Salmonella typhi setting of typhoid fever, and secondary or tertiary syphilis. The majority of hepatic abscesses used to result from portal spread intra-abdominal infections (e.g. appendicitis, diverticulitis, colitis), but now occurs primarily through the biliary tree or the arterial supply in patients suffering from some form of immune deficiency. 7) Fungal and non-hepatotrophic viral infections are often seen in immunocompromized patients. True that.